Experimental avian flu vaccine shows promise in early trial

November 13, 2013 10:06 PM

8 0

Experimental avian flu vaccine shows promise in early trial

NEW YORK (Reuters) - The first human test of an experimental vaccine against a deadly strain of avian flu, using novel technology that could produce millions of doses very quickly, produced protective antibodies in the vast majority of those who received it, scientists said on Wednesday.

The encouraging results in the early stage trial from Novavax, a biopharmaceutical company based in Rockville, Maryland, were published online in the New England Journal of Medicine.

Read more

To category page

Loading...